The molecular motor F-ATP synthase is targeted by the tumoricidal protein HAMLET

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• HAMLET (human alpha-lactalbumin made lethal to tumor cells) is known to interact with tumor cells, affecting various cellular processes.
• The precise mechanisms by which HAMLET exerts its cytotoxic effects are not fully understood.
• Investigating direct molecular targets of HAMLET could reveal key pathways involved in its anti-cancer activity.

Purpose of the Study:

• To determine if HAMLET directly affects ATP synthase function.
• To investigate the impact of HAMLET on cellular ATP levels.
• To elucidate the interaction between HAMLET and the F1F0 ATP synthase complex.

Main Methods:

• Confocal microscopy to visualize HAMLET and ATP synthase co-localization.
• Fluorescence correlation spectroscopy to quantify HAMLET binding to ATP synthase.
• Enzymatic assays to measure ATPase activity of the F-ATP synthase complex.
• Single-molecule analysis to observe the effect of HAMLET on ATP synthase rotation.

Main Results:

• HAMLET caused a dose-dependent reduction in cellular ATP levels in A549 lung carcinoma cells.
• HAMLET was found to co-localize with the α and β subunits of F1F0 ATP synthase.
• HAMLET binds to the F1 domain of ATP synthase with a dissociation constant of 20.5μM.
• HAMLET inhibited the ATPase activity of the F-ATP synthase complex and halted its rotation.

Conclusions:

• HAMLET directly interacts with and inhibits the F1F0 ATP synthase.
• Inhibition of ATP synthase by HAMLET leads to reduced cellular ATP levels.
• These findings suggest that HAMLET's tumoricidal effects may be mediated, in part, by disrupting cellular energy metabolism through ATP synthase inhibition.